Gazette.govt.nzPursuant to section 23(4A) of the Medicines Act 1981, the Minister of Health hereby renews the provisional consent to the sale, supply or use in New Zealand of the medicine set out in the Schedule hereto:
Schedule
| Product: | Polivy |
| Active Ingredient: | Polatuzumab vedotin 140mg |
| Dosage Form: | Powder for injection |
| New Zealand Sponsor: | Roche Products (NZ) Limited |
| Manufacturer: | BSP Pharmaceuticals SpA, Latina, Italy |
| Note: This renewed consent is valid for two years from 19 December 2021. | |
Dated this 13th day of December 2021.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).